Cuba’s Minister for Foreign Affairs Bruno Rodríguez will visit Nizhny Novgorod and Moscow next week, the Kremlin spokesperson announced on Friday
EFE (via 14ymedio), Moscow, 7 June 2024 — The Russian Direct Investment Fund (RDIF) will invest, in an initial phase, $11.3 million for the Cuban state-owned company BioCubaFarma to develop medicines against geriatric and oncological diseases.
This investment is part of the cooperation agreements signed between the RDIF and a consortium made up of the Cuban firm and Russian pharmaceutical companies during the International Economic Forum now being held in the Russian city of St. Petersburg, according to the official press.
When making the announcement this Thursday, the general director of the RDIF, Kiril Dmitriev, explained that the volume of investments can be increased to 113 million dollars.
Kiril Dmitriev explained that the volume of investments can be increased to 113 million dollars
“BioCubaFarma has become the first partner of the RDIF in Cuba. Combining our efforts and knowledge will allow us to develop and bring to the market innovative medicines against the most complex types of diseases caused, among other things, by age-related changes,” he said.
He also indicated that the Fund is focused on attracting the best pharmaceutical manufacturers in the world to the Russian market in order to locate the research and production of medicines, replace imports and create a base for its own production. “In Russia, BioCubaFarma has registered several companies that develop drugs for the treatment of Parkinson’s and oncological diseases,” he added.
In addition, Cuba has agreements for the development of innovative products with the Academy of Sciences and
